MALAT1 and breast carcinoma: Recently, a study published in NEJM has indicated that ASO-mediated silencing of MALAT1 in a metastasis luminal B breast cancer model can result in a cystic, poorly metastatic phenotype that closely mimicked those that arose in animals with genetic deletion of Malat1 [8].